Skip to main content

Table 1 Relationship between patient characteristics and HOXA-AS3 expression levels in tissues

From: LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling

Clinicopathologic features n HOXA-AS3 expression χ2 P value
Low High
Gender     0.467 0.464
 Male 51 27 24   
 Female 31 14 17   
Age (years)     0.668 0.414
  ≤ 50 17 7 10   
  > 50 65 34 31   
Tumor diameter (cm)     9.848 0.002**
  ≤ 4 48 31 17   
  > 4 34 10 24   
Tumor location     0.201 0.654
 Up + Middle 34 16 18   
 Down 48 25 23   
Tumor differentiation     2.390 0.122
 High + Middle 41 24 17   
 Low 41 17 24   
CEA level (ng/ml)     3.514 0.061
   ≤ 5 70 38 32   
   > 5 12 3 9   
CA 19-9 level (U/ml)     1.242 0.265
  ≤ 37 66 35 31   
   > 37 16 6 10   
HP infection     3.989 0.046*
  − 37 23 14   
   +  45 18 27   
T stage     20.500  < 0.0001****
 T1-2 32 26 6   
 T3-4 50 15 35   
N stage     25.866  < 0.0001****
 N0 39 31 8   
 N1-3 43 10 33   
  1. *< 0.05; **< 0.01; ****< 0.0001